title: Perspective on Global Measles Epidemiology and Control and the Role of Novel Vaccination Strategies.
abstract: Measles is a highly contagious, vaccine preventable disease. Measles results in a systemic illness which causes profound immunosuppression often leading to severe complications. In 2010, the World Health Assembly declared that measles can and should be eradicated. Measles has been eliminated in the Region of the Americas, and the remaining five regions of the World Health Organization (WHO) have adopted measles elimination goals. Significant progress has been made through increased global coverage of first and second doses of measles-containing vaccine, leading to a decrease in global incidence of measles, and through improved case based surveillance supported by the WHO Global Measles and Rubella Laboratory Network. Improved vaccine delivery methods will likely play an important role in achieving measles elimination goals as these delivery methods circumvent many of the logistic issues associated with subcutaneous injection. This review highlights the status of global measles epidemiology, novel measles vaccination strategies, and describes the pathway toward measles elimination.
authors.affiliation: Measles, Mumps, Rubella, and Herpesvirus Laboratory Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA 30329, USA. mcoughlin@cdc.gov.
authors.forename: Melissa M
authors.initials: MM
authors.lastname: Coughlin
authors.affiliation: Measles, Mumps, Rubella, and Herpesvirus Laboratory Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA 30329, USA. abeck@cdc.gov.
authors.forename: Andrew S
authors.initials: AS
authors.lastname: Beck
authors.affiliation: Measles, Mumps, Rubella, and Herpesvirus Laboratory Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA 30329, USA. bbankamp@cdc.gov.
authors.forename: Bettina
authors.initials: B
authors.lastname: Bankamp
authors.affiliation: Measles, Mumps, Rubella, and Herpesvirus Laboratory Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA 30329, USA. prota@cdc.gov.
authors.forename: Paul A
authors.initials: PA
authors.lastname: Rota
mesh_terms: D000818:Animals; D060740:Disease Eradication / Q000379:methods / Q000458:organization & administration; D014943:Global Health; D006801:Humans; D008457:Measles / Q000276:immunology / Q000517:prevention & control*; D008458:Measles Vaccine / Q000008:administration & dosage* / Q000276:immunology; D014611:Vaccination / Q000379:methods*; D014944:World Health Organization
chemical_list: D008458:Measles Vaccine
keywords: elimination; measles; novel vaccination strategies; surveillance; vaccine